Record Retention / Audits. Each Party will keep (and will cause its Affiliates and Sublicensees to keep) complete and accurate records pertaining to (a) in the case of Biogen, the sale or other disposition of Products (the “Biogen Records”) and (b) in the case of C4, all costs and expenses incurred with the performance of its Sandbox Activities (the “C4 Records”), in each case ((a) and (b)), in reasonable detail to permit the other Party to confirm the accuracy of all payments or costs reported, for at least the preceding [***]. Upon reasonable (but in any case no less than [***]) [***] advance notice by one Party (the “Auditing Party”) to the other Party (the “Audited Party”) and not more than once in each Calendar Year and once per audited period (in each case, except for cause), the Audited Party and its Affiliates will permit, and will cause their Sublicensees to permit, an independent certified public accounting firm of internationally recognized standing, selected by the Auditing Party and reasonably acceptable to the Audited Party, to have access during normal business hours to such of the records of the Audited Party and its Affiliates and, if applicable, their Sublicensees, as may be reasonably necessary to verify the accuracy of (i) in the case of Biogen as the Audited Party, the Biogen Records and (ii) in the case of C4 as the Audited Party, the C4 Records, for any year ending not more than [***] prior to the date of such request. The accounting firm will enter a confidentiality agreement reasonably acceptable to the Audited Party governing the use and disclosure of the Audited Party’s information disclosed to such firm, and such firm will disclose to the Auditing Party only whether information provided by the Audited Party to the Auditing Party as described in clauses (a) and (b) above was accurate and the specific details concerning any discrepancies, which information will be Confidential Information of the Audited Party.
Appears in 2 contracts
Samples: Collaborative Research and License Agreement (C4 Therapeutics, Inc.), Collaborative Research and License Agreement (C4 Therapeutics, Inc.)
Record Retention / Audits. Each Party will keep (and will cause its Affiliates and Sublicensees to keep) complete complete, true, and accurate books and records pertaining to (a) in the case of Biogen, the sale or other disposition of Products (the “Biogen Records”) and (b) in the case of C4, all costs and expenses incurred accordance with the performance of its Sandbox Activities (the “C4 Records”), in each case ((a) and (b))GAAP, in reasonable detail to permit the other Party to confirm the accuracy of all payments or costs reported, reported hereunder for at least the preceding [***]] in relation to this Agreement, including in relation to Joint Development Costs, Joint Commercialization Costs, Joint Medical Affairs Costs, Manufacturing Costs, all FTE Costs, Out-of-Pocket Costs and other costs and expenses incurred in its performance under this Agreement, and Net Sales. Upon reasonable (but in any case no less than [***]) [***] advance notice notice) by one Party (the “Auditing Party”) to the other Party (the “Audited Party”) and not more than once in each Calendar Year [**] and once [**] per audited period (in each case, except for cause), the Audited Party and its Affiliates will permit, and will cause their Sublicensees to permit, an independent certified public accounting firm of internationally internationally-recognized standingstanding (the “Auditor”), selected by the Auditing Party and reasonably acceptable to the Audited Party, to have access during normal business hours to such of the records of the Audited Party and its Affiliates and, if applicable, their Sublicensees, as may be reasonably necessary to verify the accuracy payments made or costs reported by the other Party and the related reports, statements and books of (i) in the case of Biogen accounts, as the Audited Party, the Biogen Records and (ii) in the case of C4 as the Audited Party, the C4 Records, applicable for any year ending not more than [***] prior to the date of such request. The accounting firm Auditor will enter a confidentiality agreement reasonably acceptable to the Audited Party governing the use and disclosure of the Audited Party’s information disclosed to such firm, and such firm will disclose to the Auditing Party only whether information provided by the Audited Party to the Auditing Party as described in clauses (a) and (b) above the preceding sentences was accurate and the specific details concerning any discrepancies, which information will be Confidential Information of the Audited Party.
Appears in 1 contract
Samples: Collaboration and License Agreement (Sage Therapeutics, Inc.)
Record Retention / Audits. Each Party will keep (and will cause its Affiliates and Sublicensees to keep) complete and accurate records pertaining to (a) in the case of Biogen, the sale or other disposition of Products Biogen [***] (the “Biogen Records”) and (b) in the case of C4, all costs and expenses incurred with the performance of its Sandbox Activities (the “C4 Catalyst Records”), in each case ((a) and (b)), in reasonable detail to permit the other Party to confirm the accuracy of all payments or costs reported, for at least the preceding [***]. Upon reasonable (but in any case no less than [***]) [***] advance notice by one Party (the “Auditing Party”) to the other Party (the “Audited Party”) and not more than once in each Calendar Year and once per audited period (in each case, except for cause)[***], the Audited Party and its Affiliates will permit, and will cause their Sublicensees to permit, an independent certified public accounting firm of internationally recognized standing, selected by the Auditing Party and reasonably acceptable to the Audited Party, to have access during normal business hours to such of the records of the Audited Party and its Affiliates and, if applicable, their Sublicensees, as may be reasonably necessary to verify the accuracy of (i) in the case of Biogen as the Audited Party, the Biogen Records Party [***] and (ii) in the case of C4 Catalyst as the Audited Party, the C4 Records, for any year ending not more than [***] prior to the date of such request]. The accounting firm will enter a confidentiality agreement reasonably acceptable to the Audited Party governing the use and disclosure of the Audited Party’s information disclosed to such firm, and such firm will disclose to the Auditing Party only whether information provided by the Audited Party to the Auditing Party as described in clauses (a) and (b) above was accurate and the specific details concerning any discrepancies, which information will be Confidential Information of the Audited Party.
Appears in 1 contract
Samples: License and Collaboration Agreement (Catalyst Biosciences, Inc.)
Record Retention / Audits. Each Party will keep (and will cause its Affiliates and Sublicensees to keep) complete complete, true, and accurate books and records pertaining to (a) in the case of Biogen, the sale or other disposition of Products (the “Biogen Records”) and (b) in the case of C4, all costs and expenses incurred accordance with the performance of its Sandbox Activities (the “C4 Records”), in each case ((a) and (b))GAAP, in reasonable detail to permit the other Party to confirm the accuracy of all payments or costs reported, reported hereunder for at least the preceding [***]] in relation to this Agreement, including in relation to Joint Development Costs, Joint Commercialization Costs, Joint Medical Affairs Costs, Manufacturing Costs, all FTE Costs, Out-of-Pocket Costs and other costs and expenses incurred in its performance under this Agreement, and Net Sales. Upon reasonable (but in any case no less than [***]) [***] advance notice notice) by one Party (the “Auditing Party”) to the other Party (the “Audited Party”) and not more than once in each Calendar Year [**] and once [**] per audited period (in each case, except for cause), the Audited Party and its Affiliates will permit, and will cause their Sublicensees to permit, an independent certified public accounting firm of internationally internationally-recognized standingstanding (the “Auditor”), selected by the Auditing Party and reasonably acceptable to the Audited Party, to have access during normal business hours to such of the records of the Audited Party and its Affiliates and, if applicable, their Sublicensees, as may be reasonably necessary to verify the accuracy payments made or costs reported by the other Party and the related reports, statements and books of (i) in the case of Biogen accounts, as the Audited Party, the Biogen Records and (ii) in the case of C4 as the Audited Party, the C4 Records, applicable for any year ending not more than [***] prior to the date of such request. The accounting firm Auditor will enter a confidentiality agreement reasonably acceptable to the Audited Party governing the use and disclosure of the Audited Party’s information disclosed to IF " DOCVARIABLE "SWDocIDLocation" 4096" = "1" " DOCPROPERTY "SWDocID" ActiveUS 185387629v.1" "" such firm, and such firm will disclose to the Auditing Party only whether information provided by the Audited Party to the Auditing Party as described in clauses (a) and (b) above the preceding sentences was accurate and the specific details concerning any discrepancies, which information will be Confidential Information of the Audited Party.
Appears in 1 contract
Samples: Collaboration and License Agreement (Sage Therapeutics, Inc.)